Bio Aurum Srl is a health care startup based in Italy with a focus on improving health through nature. The company spearheads the medical research and development of nature-based treatments for a range of neurodegenerative diseases. Bio Aurum combines a scientific approach with stringent clinical validation to advance medicine. The research is centered around the therapeutic properties of saffron constituents, with evidence supporting antioxidant, anti-inflammatory, and neuroprotective properties, among many others. The company recently secured a €193.00K Pre Seed Round investment on 01 September 2020 from CDP Equity. This funding will likely support Bio Aurum's efforts to further develop and validate their nature-based treatments for neurodegenerative diseases.
No recent news or press coverage available for Bio Aurum Srl.